The SUMMIT Study

  • Home
  • The SUMMIT Study
NCL Wide

Update on 25 May 2021

Recruitment of participants into the SUMMIT study, the largest lung cancer screening study in Europe, has been completed with a total 13,035 north and east London residents taking part.

For more information on the SUMMIT study please visit the UCLH website.

For queries email uclh.hcpsummitstudy@nhs.net


Overview

UCLH is carrying out the SUMMIT Study to detect lung cancer early using low-dose CT (LDCT) screening of at-risk individuals and to support development of a new blood test for early detection of multiple cancer types. 

The SUMMIT Study, which began in spring 2019, has two aims: to detect lung cancer early using the proven method of low-dose CT (LDCT) screening of at-risk individuals; and to support development of a new blood test for early detection of multiple cancer types, including lung cancer. In addition, the study will provide evidence to inform a potential future national lung cancer screening programme. The study has so far recruited over 12,000 people aged 55-77 with a smoking history from north and east London. 

 

If you have any questions, contact the study team
e: uclh.HCPsummitstudy@nhs.net.

Find out more information on the SUMMIT Study

 

Video: About The SUMMIT Study

w: https://youtu.be/C78K_n-bBwA

SUMMIT lung cancer screening: Information Governance

Download DOCX, 12.51 KB